Director Dealing

Summary by AI BETAClose X

Vulpes Testudo Fund, closely associated with Non-Executive Director Martin Diggle, purchased 3,150,000 ordinary shares in Scancell Holdings plc on September 12, 2025. The shares, with a value of 0.1p each, were bought at a price of 8.861 pence per share. Following this transaction, the combined holdings of Vulpes Life Science Fund and Vulpes Testudo Fund amount to 143,537,037 ordinary shares, representing 13.83% of the company's total shares.

Disclaimer*

UK 100

Latest directors dealings